Nine midsize pharmaceutical companies signed on to most-favored-nation deals with President Donald Trump, lowering drug prices for U.S. consumers.

The string of deals builds on the Trump administration's push to link the nation's drug prices to cheaper ones abroad.

Nine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of companies to twenty-six manufacturers. …